Lv3
390 积分 2025-12-02 加入
Sotatercept: The First FDA-Approved Activin A Receptor IIA Inhibitor Used in the Management of Pulmonary Arterial Hypertension
3小时前
已完结
Sotatercept: A New Frontier in Pulmonary Arterial Hypertension Treatment
3小时前
已完结
The Potential Impact of Sotatercept on Long-Term Disability in Commercially Insured Patients with Pulmonary Arterial Hypertension in the United States: An Exercise in Actuarial Modeling
4小时前
已完结
Efficacy and Safety of Sotatercept in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
4小时前
求助中
Sotatercept for pulmonary arterial hypertension on background therapy: a systematic review and meta-analysis of randomized controlled trials
4小时前
已关闭
Clinical outcomes and safety of sotatercept in pulmonary arterial hypertension: A systematic review and meta-analysis of randomized controlled trials
4小时前
已完结
Efficacy and safety of sotatercept in pulmonary arterial hypertension: a meta-analysis of randomized controlled trials
5小时前
已完结
Sotatercept for pulmonary arterial hypertension on background therapy: a systematic review and meta-analysis of randomized controlled trials
5小时前
已完结
Drug-induced headache reports: a comprehensive disproportionality and time-to-onset pharmacovigilance study using the FAERS database (2018-2024)
4天前
已完结
A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension
9天前
已完结
皖公网安备34019202002308
